Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

164.35 -2.41 (-1.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,102,081
Open 164.03
Bid (Size) 160.20 (1)
Ask (Size) 165.20 (1)
Prev. Close 166.76
Today's Range 162.40 - 166.44
52wk Range 92.14 - 183.00
Shares Outstanding 136,546,580
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Look Back at Immuno-Oncology Stocks’ Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
NTRA Q1 Earnings Call: Growth in Oncology and Women's Health Drives Guidance Increase
Genetic testing company Natera (NASDAQ:NTRA). reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 36.5% year on year to $501.8 million. The company’s full-year revenue... 
Via StockStory

Performance

YTD
+2.3%
+2.3%
1 Month
+7.9%
+7.9%
3 Month
+15.3%
+15.3%
6 Month
-1.3%
-1.3%
1 Year
+46.0%
+46.0%

More News

Read More
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Natera Announces Medicare Coverage for Signatera™ Genome
From Natera, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Preview: Natera's Earnings
Via Benzinga
Peering Into Natera's Recent Short Interest
Via Benzinga
SignateraTM Genome Clinical Performance Highlighted at ASCO 2025
From Natera, Inc.
Via Business Wire
2 Cash-Heavy Stocks for Long-Term Investors and 1 to Be Wary Of
Via StockStory
3 Mid-Cap Stocks Worth Your Attention
Via StockStory
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting
From Natera, Inc.
Via Business Wire
Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today
Via Benzinga
8 Analysts Have This To Say About Natera
Via Benzinga
Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales
Via StockStory
Natera Reports First Quarter 2025 Financial Results
From Natera, Inc.
Via Business Wire
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress
From Natera, Inc.
Via Business Wire
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows
From Natera, Inc.
Via Business Wire
What To Expect From Natera’s (NTRA) Q1 Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera
From Natera, Inc.
Via Business Wire
Natera to Report its First Quarter Results on May 8, 2025
From Natera, Inc.
Via Business Wire
Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction
From Natera, Inc.
Via Business Wire
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary Of
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test
From Natera, Inc.
Via Business Wire

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 164.35
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 06/12/25 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 22.44B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 22B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.